Log inSign up
Amatica Health
69 posts
Image
user avatar
Amatica Health
@amaticahealth
Patient-centred chronic disease research
amaticahealth.com
Joined August 2023
10
Following
2,197
Followers
  • user avatar
    Amatica Health
    @amaticahealth
    Jan 3, 2025
    First look at our novel research findings in #LongCOVID and #MECFS: Our initial data shows elevated Arginase-1 (ARG1) in many patients compared to HC. While we need more control data for statistical significance, this pattern aligns with known disease mechanisms and symptoms 🧵
    Image
    11K
  • user avatar
    Amatica Health
    @amaticahealth
    Feb 1, 2025
    🔬Alterations in serum PINK1 in ME/CFS & LC PINK1 acts as a 'quality control sensor', accumulating on damaged mitochondria to trigger removal and recycling (called mitophagy) - Elevated vs reference control (p=0.0171) - Distinct high/low pattern - Points to patient subgroups
    Image
    Image
    8.1K
  • user avatar
    Amatica Health
    @amaticahealth
    Jun 3, 2024
    Who we are: ME/CFS patient researchers (mostly COVID-triggered) We are working to bring patients the tests they need to understand their disease Our goal is to drive research forward towards diagnostic biomarkers and personalised treatments
    4.6K
  • user avatar
    Amatica Health
    @amaticahealth
    Jul 23, 2025
    We’re so excited to release the next Amatica Health project: Whole blood RNA sequencing 20,000 gene expression results. 1,500 biological pathways. All in one test amaticahealth.com/me-cfs-long-co…
    Image
    10K
  • user avatar
    Amatica Health
    @amaticahealth
    May 30, 2025
    Clustering of energy, metabolic & O2-sensing markers reveals two distinct patient groups in Long COVID/ME/CFS The group with more abnormal energy/metabolic/O2-sensing shows significant alterations in inflammatory signalling & vascular regulation pathways
    Image
    Image
    Image
    6.8K
  • user avatar
    Amatica Health
    @amaticahealth
    May 23, 2025
    🔬New insights from LC/MECFS similarity networks We mapped 31 biomarkers across mitochondrial, immune, vascular, redox, and neuroinflammation pathways Natural clusters emerge linking patients who truly share biology—and separating those who don't A step towards precision care
    Image
    5.3K
  • user avatar
    Amatica Health
    @amaticahealth
    Jan 3, 2025
    Replying to @amaticahealth
    🔬 Future treatment implications: ARG1 inhibitors currently in cancer trials could potentially be explored for LC/ME patients with elevated ARG1 We plan to work with clinicians on investigating compassionate use pathways once these drugs complete safety trials
    1.2K
  • user avatar
    Amatica Health
    @amaticahealth
    Jan 3, 2025
    Replying to @amaticahealth
    ARG1 (Arginase-1) is an enzyme that breaks down L-arginine, affecting NO production and immune function Overexpression creates a cascade of effects across multiple systems - from blood vessels to brain function. In LC and MECFS, elevated ARG1 could contribute to many symptoms
    Image
    1.7K
  • user avatar
    Amatica Health
    @amaticahealth
    Feb 1, 2025
    Replying to @amaticahealth
    Help advance LC & MECFS research while gaining insight into your own condition Register to join batches 2&3 here: amaticahealth.com/me-cfs-long-co… Our goal: Analyse hundreds of samples to understand rare subgroups and symptom associations Follow @amaticahealth for research updates
    2.6K
  • user avatar
    Amatica Health
    @amaticahealth
    Jan 3, 2025
    Replying to @amaticahealth
    By combining detailed symptom questionnaires with molecular data (like ARG1), we aim to understand what drives disease subtypes in #LongCOVID & #MECFS This will help match patients to treatments and improve trial success through better subgroup identification 🧬🔍
    Image
    919
  • user avatar
    Amatica Health
    @amaticahealth
    Apr 28, 2025
    Announcing our Long COVID and ME/CFS questionnaire platform alpha release We aim to map every symptom & history layer to resolve hidden sub-groups—enabling precision diagnostics and personalised care Seeking alpha testers to help refine it: my.amaticahealth.com/alpha
    Image
    4.2K
  • user avatar
    Amatica Health
    @amaticahealth
    Jan 3, 2025
    Replying to @amaticahealth
    Help advance LC & MECFS research while gaining insight into your own condition Register to join batches 2&3 here: amaticahealth.com/pages/31-marke… Our goal: Analyse hundreds of samples to understand rare subgroups Follow @amaticahealth for research updates
    636
  • user avatar
    Amatica Health
    @amaticahealth
    Jan 3, 2025
    Replying to @amaticahealth
    📈 More insights coming soon! With 27 markers still to analyse & recruitment open for new batches, we're building a dataset to unlock connections between symptoms & molecular signatures
    752
  • user avatar
    Amatica Health
    @amaticahealth
    Mar 6, 2025
    Orignal Research 🔬📷 47% of ME/CFS patients showed elevated α-NAGA (nagalase) levels compared to controls Although the overall difference wasn’t statistically significant (p=0.1704), we will focus analysis within this subgroup & expand the study with more participants📷🧵
    Image
    3K

New to X?

Sign up now to get your own personalized timeline!

Create account

By signing up, you agree to the Terms of Service and Privacy Policy, including Cookie Use.

Terms·Privacy·Cookies·Accessibility·Ads Info·© 2026 X Corp.
Don't miss what's happening
People on X are the first to know.
Log inSign up
Advertisement
Advertisement